Invasive pulmonary aspergillosis secondary to microwave ablation: a multicenter retrospective study. (31st December 2018)

• Record Type: Journal Article
• Authors: Huang, Guanghui; Ye, Xin; Yang, Xia; Wang, Chuntang; Zhang, Licheng; Ji, Guangdong; Zhang, Kaixian; Wang, Huili; Zheng, Aimin; Li, Wenhong; Wang, Jiao; Han, Xiaoying; Wei, Zhigang; Meng, Min; Ni, Yang
• Is Part Of: International journal of hyperthermia. Volume 35:Number 1(2018)
• Page Start: 71
• Page End: 78
• Publication Date: 2018-12-31
• Subjects: Complication -- invasive pulmonary aspergillosis -- lung tumors -- microwave ablation; Thermotherapy -- Periodicals; 615.832
• DOI: 10.1080/02656736.2018.1476738
• Languages: English
• ISSNs: 0265-6736

Abstract

Abstract: Purpose: Invasive pulmonary aspergillosis (IPA) is a life-threatening complication of microwave ablation (MWA) during the treatment of primary or metastatic lung tumors. The purpose of this study was to investigate the clinical, radiological and demographic characteristics and treatment responses of patients with IPA after MWA. Materials and methods: From January 2011 to January 2016, all patients who were treated by MWA of their lung tumors from six health institutions were enrolled in this study. Patients with IPA secondary to MWA were identified and retrospectively evaluated for predisposing factors, clinical treatment, and outcome. Results: The incidence of IPA secondary to lung MWA was 1.44% (23/1596). Of the 23 patients who developed IPA, six died as a consequence, resulting in a high mortality rate of 26.1%. Using computed tomography (CT), pulmonary cavitation was the most common finding and occurred in 87.0% (20/23) of the patients. Sudden massive hemoptysis was responsible for one-third of the deaths (2/6). Most patients (22/23) received voriconazole as an initial treatment, and six patients with huge cavities underwent intracavitary lavage. Finally, 17 patients (73.9%) achieved treatment success. Conclusions: Lung MWA may be an additional host risk factor for IPA, particularly in elderly patients with underlying diseases and in patients who have recently undergone chemotherapy. Early and accurate diagnosis of IPA after MWA is critical for patient prognosis. Voriconazole should be given as the first-line treatment as early as possible. Bronchial artery embolization or intracavitary lavage may be required in some patients.